Page last updated: 2024-11-07

paramethasone and Vitiligo

paramethasone has been researched along with Vitiligo in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imamura, S1
Tagami, H1

Other Studies

1 other study available for paramethasone and Vitiligo

ArticleYear
Treatment of vitiligo with oral corticosteroids.
    Dermatologica, 1976, Volume: 153, Issue:3

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Betamethasone; Child, Presch

1976